Related Experiment Videos
Prognostic factors in mesangioproliferative glomerulonephritis
Bjørn Egil Vikse1, Leif Bostad, Knut Aasarød
1The Norwegian Kidney Register, Institute of Medicine, The Gade Institute, Haukeland University Hospital, Bergen, Norway. bjorn.vikse@student.uib.no
Summary
Identifying mesangioproliferative glomerulonephritis (MPGN) progression is possible using clinical and histopathological factors. Young age, low albumin, and urinary casts are key clinical predictors of kidney failure risk.
Area of Science:
- Nephrology
- Pathology
- Internal Medicine
Background:
- Mesangioproliferative glomerulonephritis (MPGN) is a kidney disease.
- Understanding factors predicting MPGN progression is crucial for patient management.
Purpose of the Study:
- To analyze clinical and histopathological variables in MPGN patients.
- To determine predictors of progression to end-stage renal failure (ESRF) and death.
Main Methods:
- Retrospective study of 273 MPGN patients diagnosed between 1988-1990 in Norway.
- Follow-up duration of 34.8 months.
- Kaplan-Meier and multivariable analyses were used.
Main Results:
- Glomerular IgA deposits did not impact prognosis.
- Clinical predictors of ESRF included increased creatinine, proteinuria, high blood pressure, low albumin, urinary casts, and older age.
- Histopathological predictors included mesangial sclerosis, glomerular crescents/necroses, nephrosclerosis, and interstitial damage.
Conclusions:
- Clinical and histopathological data can identify high-risk MPGN patients at biopsy.
- Young age, decreased serum albumin, and urinary granular casts are significant clinical risk factors.
- Interstitial damage is the most critical histopathological predictor of ESRF.